Skip Navigation


JAC Advance Access originally published online on June 22, 2007
Journal of Antimicrobial Chemotherapy 2007 60(2):406-409; doi:10.1093/jac/dkm211
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/2/406    most recent
dkm211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saravolatz, L. D.
Right arrow Articles by Johnson, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saravolatz, L. D.
Right arrow Articles by Johnson, L. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus

Louis D. Saravolatz*, Joan Pawlak and Leonard B. Johnson

Department of Internal Medicine, St John Hospital and Medical Center, Detroit, MI, USA

Received 23 February 2007; returned 6 April 2007; revised 15 May 2007; accepted 17 May 2007

* Corresponding author. Tel: +1-313-343-3362; Fax: +1-313-343-7784; E-mail: louis.saravolatz{at}stjohn.org

Objectives: This study compared the activity of telavancin, a novel multivalent lipoglycopeptide with rapid bactericidal activity, with those of five standard antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) against isolates of community-associated MRSA (CA-MRSA).

Methods: Microdilution tests performed according to CLSI guidelines using cation-adjusted Mueller–Hinton broth were used to determine the MIC values of telavancin, quinupristin/dalfopristin, vancomycin, trimethoprim/sulfamethoxazole, linezolid and daptomycin versus 60 CA-MRSA isolates. MBC values of telavancin were determined according to CLSI guidelines and American Society for Microbiology standards. PFGE was performed using the restriction enzyme SmaI. Samples from three predominant pulsed-field types were typed by multilocus sequence typing. Staphylococcal cassette chromosome mec typing was determined by multiplex PCR. The Panton-Valentine leucocidin (PVL) genes (lukS-PV and lukF-PV) were identified by PCR.

Results: The telavancin MIC90 and MBC90 values for this collection of 60 CA-MRSA isolates were 0.5 and 1 mg/L, respectively, with MIC and MBC values both ranging from 0.25 to 1 mg/L. Telavancin was found to be bactericidal in this study, as its MBC was no more than 2-fold higher than its MIC for all CA-MRSA isolates tested except one. (A single isolate yielded an MBC/MIC ratio of 4.) PVL- and non-PVL-producing strains demonstrated similar susceptibility to telavancin and comparator agents.

Conclusions: Based on in vitro activity, telavancin should be an effective agent against CA-MRSA.

Keywords: CA-MRSA , PVL , S. aureus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. M. Finegold, M. Bolanos, P. H. Sumannen, and D. R. Molitoris
In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3996 - 4001.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. O. Darouiche, M. D. Mansouri, and M. J. Schneidkraut
Comparative Efficacies of Telavancin and Vancomycin in Preventing Device-Associated Colonization and Infection by Staphylococcus aureus in Rabbits
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2626 - 2628.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
L. Charneski, P. N Patel, and D. Sym
Telavancin: A Novel Lipoglycopeptide Antibiotic
Ann. Pharmacother., May 1, 2009; 43(5): 928 - 938.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.